Arine vs TailorMed (2026)
Both address why patients do not take their medicines, and they answer different halves of it. Arine works the clinical half for health plans, ingesting clinical, socioeconomic and behavioral data across a membership to find people whose regimen is failing them. Its platform holds HITRUST r2 and it names client results. TailorMed works the financial half for providers and pharmacies, finding at risk patients and matching them to assistance so the medicine is affordable in the first place. A patient can be identified perfectly by one and still not fill the prescription for reasons the other addresses. Both report self measured savings, and neither publishes results by patient group, which matters because both decide who gets helped.
- It ingests clinical, socioeconomic and behavioral data across a plan's membership to find members at risk before an event, and its platform holds HITRUST r2.
- Results are named to real clients with quantified savings per engaged member, though the figures are self reported.
- The buyer is the plan, so the workflow and contracting are shaped for population level medication management.
- It identifies financially at risk patients and matches them to assistance programs, which is provider side work aimed at the patient's ability to pay.
- The incentive is aligned with the patient affording their care rather than with a savings figure reported to a plan.
- Financial navigation reaches across therapies and payers rather than optimizing one membership.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Arine and TailorMed are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Arine | TailorMed |
|---|---|---|
| Primary category | Medication Safety & Prescribing | Healthcare Administrative Automation |
| Founded | 2019 | 2016 |
| Headquarters | San Francisco, California, United States | New York, New York, United States |
| Website | arine.io | tailormed.com |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Arine sells medication intelligence to health plans rather than to hospitals. The platform ingests clinical, socioeconomic and behavioral data across a plan's membership, identifies members at risk of medication related problems before they produce an event, generates personalized care plans for clinical pharmacists to act on, and separately analyses prescriber behavior so a plan can direct education and recommendations at the clinicians writing the prescriptions.
Source: AI Health Index, September 2026
Medication access and financial navigation platform that identifies financially at risk patients, matches them against a large network of financial assistance and manufacturer programs, and automates enrollment inside health system workflows using live EHR data.
Source: AI Health Index, September 2026
Questions buyers ask
How do Arine and TailorMed work with the EHR?
For Arine, one integration crosses into the clinical workflow: a partnership with a drug price transparency company brings cost information toward the point of prescribing, and the prescriber facing analytics product delivers to clinicians rather than to plan staff. The mechanism by which recommendations reach a prescriber's workflow is undescribed, and for a product whose value depends on a clinician acting, that path matters most.
The Core page says the platform is deeply integrated with health system IT, keeps patient, prescription and program data in sync via HL7 and FHIR, the TailorMed API or SFTP, and populates program forms from live EHR data, and it verifies benefits through a clearinghouse. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 20, 2026. No vendor pays for placement.
How are Arine and TailorMed priced and sold?
The site promises guaranteed outcomes and immediate return on investment and expresses its results per engaged member per year, a unit that answers the value question and leaves the cost question untouched; nothing says whether Arine charges per member, per engaged member, per program or on an outcome linked basis, or what the guarantee commits it to.
For TailorMed, the company monetizes on several sides at once: a care team platform sold to providers, a patient facing product, a tech enabled service arm, and separately digital solutions sold to life sciences companies to improve access and time to therapy across its network. A provider is buying from a company that is also selling to the manufacturers whose assistance programs the platform matches patients into. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 20, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers.
Both vendors sell outcomes measured by the party being paid for them, and the savings figures on both sides are self reported, so ask for the denominator, the comparison group and who computed the result. Neither publishes a subgroup analysis. In medication management that gap matters twice over: a model that decides who gets a pharmacist intervention and a workflow that decides who is offered financial assistance both fail quietly for the populations they reach least well. Arine states no HIPAA status. Neither publishes a price.